Jianwei Shen

Title: Jianwei Shen: Innovator in Prostaglandin E2 Binding Proteins

Introduction

Jianwei Shen is a notable inventor based in Lake Bluff, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of prostaglandin E2 binding proteins. His work has implications for various medical applications, especially in treating disorders related to prostaglandin E activity.

Latest Patents

Jianwei Shen holds a patent for "Prostaglandin E2 binding proteins and uses thereof." This invention encompasses prostaglandin E (PGE) binding proteins and relates to antibodies that are wild-type, chimeric, CDR grafted, and humanized. The preferred antibodies exhibit high affinity for prostaglandin E and are capable of neutralizing prostaglandin E activity both in vitro and in vivo. The patent also details methods for making and using these antibodies, which are useful for detecting prostaglandin E and inhibiting its activity in individuals suffering from disorders where prostaglandin E activity is detrimental.

Career Highlights

Jianwei Shen is associated with AbbVie Inc., a leading global biopharmaceutical company. His work at AbbVie has allowed him to focus on innovative solutions in the field of biotechnology. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medical science.

Collaborations

Some of Jianwei Shen's coworkers include Maria Harris and Anwar Murtaza. Their collaborative efforts contribute to the innovative environment at AbbVie, fostering advancements in biotechnology and therapeutic solutions.

Conclusion

Jianwei Shen's contributions to the field of prostaglandin E2 binding proteins highlight his role as an innovator in biotechnology. His patent work and collaboration with colleagues at AbbVie Inc. underscore the importance of innovation in addressing medical challenges.